Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Quinnova Pharmaceuticals

Request full access

Exeltis USA Dermatology, Inc. (Formerly Quinnova Pharmaceuticals LLC.) | Rethinking Healthcare

Newtown, United StatesFounded 2003Biotech & Life Sciences

About Quinnova Pharmaceuticals

Quinnova is a specialized company in the pharmaceuticals sector, focusing on the supply of high-quality peptides and supplements aimed at bodybuilding and health optimization. Established in 2007, Quinnova has built a reputation for providing reliable and effective products that cater to both individual consumers and professional athletes. The company operates primarily in the online retail market, offering a wide range of products including MK 677 Ibutamoren, 5 Amino 1MQ, and other specialized supplements. Quinnova's business model revolves around direct-to-consumer sales through its e-commerce platform, ensuring a seamless purchasing experience with detailed product guides, peer-reviewed study insights, and comprehensive customer service. Revenue is generated through product sales, with a focus on repeat customers and subscription models for regular supply. The company also emphasizes privacy and data protection, ensuring customer information is handled with the highest standards of security.

Source: Dealroom company data

At a glance

Status
Closed
Employees
8
Open positions
None listed
Industry
Health
Sub-industry
Pharmaceutical
Sector
Biotechnology, Biotech and Pharma, Hard Tech, DT and LS, science-based
Client focus
B2C

Funding history

3 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
CONVERTIBLE✓Equity / VC Sep 2010 $300K — Undisclosed —
SERIES B✓Equity / VC Oct 2009 $17M $70M Safeguard Scientifics —
Showing the latest 2 of 3 recorded eventsBook a demo for the full funding history →

Growth signals

Quinnova Pharmaceuticals website traffic

Latest recorded traffic for Quinnova Pharmaceuticals is 11K monthly website visits, down 38.9% over the last three months. Quinnova Pharmaceuticals's team grew 0% over the past year.

Latest monthly visits11K 3-month web change-38.9% 1-year team growth0%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Showing 8 of the closest matchesCompare every metric →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Quinnova Pharmaceuticals in the Newtown ecosystem

Live from Dealroom

The Quinnova Pharmaceuticals office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

3 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A1 investor entered at this stage

  • Safeguard Scientifics

Other known investors2 additional known investors

  • H.I.G. HealthBridge
  • HIG Capital
Team profiled 8 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 2 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
🇺🇸 United States · Newtown HQ
Book a demo for the full country breakdown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Quinnova Pharmaceuticals on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Quinnova Pharmaceuticals’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.